Scientists test common diabetes pills for hidden Anti-Inflammatory powers
NCT ID NCT06812429
Summary
This small, early-stage study looked at whether a type of diabetes medication (SGLT2 inhibitors) could reduce inflammation linked to heart and kidney health. Researchers gave the drug to 6 healthy adults who had never taken it before and measured changes in their inflammation markers over three days. The goal was to gather basic information, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.